N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation

  • Deric M. Park
  • , Jie Li
  • , Hiroaki Okamoto
  • , Oluwaseun Akeju
  • , Stephanie H. Kim
  • , Irina Lubensky
  • , Alexander Vortmeyer
  • , James Dambrosia
  • , Robert J. Weil
  • , Edward H. Oldfield
  • , John K. Park
  • , Zhengping Zhuang

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

Nuclear receptor corepressor (N-CoR) is a critical regulator of neural stem cell differentiation. Nuclear localization of N-CoR is a feature of undifferentiated neural stem cells and cytoplasmic translocation of N-CoR leads to astrocytic differentiation. Comparative proteomic analysis of microdissected glioblastoma multiforme (GBM) specimens and matched normal glial tissue reveals increased expression of N-CoR in GBM. In GBM primary cell cultures, tumor cells with nuclear localization of N-CoR demonstrate an undifferentiated phenotype, but are subject to astroglial differentiation upon exposure to agents promoting phosphorylation of N-CoR and its subsequent translocation to the cytoplasm. Treatment of glioma cell lines with a combination of retinoic acid and low-dose okadaic acid decreases the corepressor effect of N-CoR and has a striking synergistic effect on growth inhibition. The identification of N-CoR in GBM provides insights into the tumorigenesis process and supports the development of differentiation-based therapeutic strategies.

Original languageEnglish
Pages (from-to)467-470
Number of pages4
JournalCell Cycle
Volume6
Issue number4
DOIs
StatePublished - Feb 15 2007

Keywords

  • Cancer stem cell
  • Differentiation
  • Glioma
  • N-CoR
  • Retinoic acid

Fingerprint

Dive into the research topics of 'N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation'. Together they form a unique fingerprint.

Cite this